ОСТИАЛЬНАЯ АБЛАЦИЯ ЛЕГОЧНЫХ ВЕН У ПАЦИЕНТОВ C РАЗНЫМИ ФОРМАМИ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ
Аннотация
C целью оценки безопасности и эффективности остиалъной аблации легочных вену пациентов с различными формами фибрилляции предсердий в исследование включены 86 пациентов; основную группу составили 43 пациента, которым выполнено оперативное вмешательство, контрольную - 43 пациента которым была назначена антиаритмическая терапия и непрямые антикоагулянты.
Об авторах
Д. С. Лебедев
Санкт-Петербургский ГМУ им. акад. И.П.Павлова; Санкт-Петербургская ГМА им. И.И.Мечникова; городская многопрофильная больница №2
Россия
Санкт-Петербург
Россия
Санкт-Петербург
В. А. Маринин
Санкт-Петербургский ГМУ им. акад. И.П.Павлова; Санкт-Петербургская ГМА им. И.И.Мечникова; городская многопрофильная больница №2
Россия
Санкт-Петербург
Россия
Санкт-Петербург
В. С. Оршанская
Санкт-Петербургский ГМУ им. акад. И.П.Павлова; Санкт-Петербургская ГМА им. И.И.Мечникова; городская многопрофильная больница №2
Россия
Санкт-Петербург
Россия
Санкт-Петербург
Список литературы
1. Кушаковский М.С. Фибрилляция предсердий. ИКФ, Фолиант, СПб., 1999
2. Подлесов А.М. Бойцов С. А., Егоров Д.Ф. СПБ 2001, стр. 8-10.
3. Feinberg W.M., Blackshear J.L., Laupacis A. et al. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 1995; 155:469-73
4. Benjamin E.J., Wolf RA. et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998,98:946-952.
5. Levy S. et al. Atrial fibrillation: current knowledge and recommendations for management. Eur. Heart J. 1998; 19: 1294-1302.
6. Bigger J.T. Epidemiological and mechanistic studies of atrial fibrillation as a basis of treatment strategies. Circulation 1998; 98:943-945.
7. Brand F. N., Abbot R.D. et al. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham study. JAMA 1985; 254: 3449-53.
8. Kannel W.B., Abbot R.D. et al. Epidemiologic futures of chronic atrial fibrillation: the Framingham study. N. Engl. J. Med. 1982;306:1018-22.
9. Hart R.G. et al. Atrial fibrillation and stroke
10. Page R., Tilsch T.W. Asymptomatic or “Silent” Atrial Fibrillation. Circulation 2003; 107; 1141-1145.
11. Nattel S. New ideas about atrial fibrillation 50 years on. Nature. 2002; 415; 219-226
12. Allessie M.A. et al. Experimental evaluation of Moe’s wavelet hypothesis of atrial fibrillation. In Zipes D.P Cardiac Electrophysiology and Arrhythmias Orlando, WB Saunders; 1985:265-275.
13. Alessie M.A., Boyden RA. Pathophysiology and prevention of atrial fibrillation. Circulation 2001; 103:769-777.
14. Wijffles M.C. et al. Atrial fibrillation beget atrial fibrillation: a study in awake chronically instrumented goats. Circulation 1995; 92:1954-1968.
15. Arora R. Verheule S., Scott L. et al. Arrytmogenic Substrate of the Pulmonary Veins Assessed by High-Resolution Optical Mapping. Circulation 2003; 107; 1816-1821.
16. Tsai C. F. Pulmonary vein ablation: role in prevention atrial fibrillation. Current Opinion in Cardiology. Lippicott W&W2003; 18:39-46.
17. Lin W. S. Catheter ablation of paroxysmal atrial fibrillation initiated by non pulmonary vein ectopy. Circulation. 2003;107:3176-3183.
18. Scheinman M.M., Morady F. Nonfarmacological Approaches to Atrial Fibrillation. Circulation. 2001; 103; 21202125.
19. Blum N. A. et al. Development of the cardiac condaction tissue in human embryos using HNK-I antigen expression: possible relevans for understanding of abnormal atrial automaticy. Circulation. 1999; 99:800-806.
20. Kantachuvessiri A. et al. Pulmonary veins: Preferred site for catheter ablation of atrial fibrillation. Heart and lung.2002; 3:271-278.
21. Chen S.A., Hsieh M.N., Tai T.C. et al. Initiation of atrial fibrillationby ectopic beats originating from the pulmonary veins. Circulation 1999; 100:1879-1866.
22. Page L. et al. Beta-blokers for atrial fibrillation: must we consider asymptomatic arrhythmias ? JACC 2000; 36: 147-150.
23. Haissaguerre M. et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 1998; 339: 659-666.
24. Haissaguerre M. et al. Electrophysiological end point for cateter ablation of atrial fibrillation initiated from multiple pulmonary vein foci. Circulation. 2000; 101:1409-1417.
25. Lau C.P, Tse H.F. et al. Defibrillation-gided radiofrequency ablation of AF secondary to atrial focus. JACC 1999; 33: 1217-1226.
26. Stable G., Turco P, La Rocca V. et al. Is pulmonary vein isolation nessesery for curing atrial fibrillation ? Circulation. 2003;108:657-660.
27. Hwang C., Chen S.A. et al. Idiopatic paroxysmal AF induced by a focal discharge mechanism in the left superior pulmonary vein: possible role of the ligament Marshall. J. Cardiovasc. Electrophysiol. 1999; 10: 636-648.
28. Chen S .A., Tai S .T. Radiofrequency catheter ablation of atrial fibrillation initiated by pulmonary vein ectopic beats J. Cardio vase. Electrophysiol. 2000; 11:218-227.
29. Pappone C. et al. Circumferential radiofrequency ablation of pulmonary vein ostia. A new anatomic approach for curing atrial fibrillation. Circulation. 2000; 102:2619-2628.
30. Pappone C. et al. Atrial electroanatomic remodeling after circumferential radiofrequency vein ablation. Efficacy of the anatomic approach in a large cohort of patients with atrial fibrillation. Circulation. 2001; 104:2539-2544.
31. Oral H., Knight B.P.et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002; 105:1077-1081.
32. Pappone C. The Who, What, Why, and How-To Guide for Circumferential Pulmonary Vein Ablation. J Cardiovasc Electrophysiol 15(10): 1226-1230,2004
33. Lloyd-Jones DM, Wang TJ, Leip E, et al. Lifetime risk for development of atrial fibrillation. Circulation 2004; 110:10421046.
34. Fisher J.D.; Spinelli M.A.; Mookherj ее D. Atrial Fibrillation Ablation: Reaching the Mainstream Pacing Clin Electrophysiol. 2006; 29(5): 523-537.
35. Karch MR; Zrenner B; Deisenhofer I. et al. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation 2005; 111(22): 2875-80.
36. Flaker G. C.; Belew K. et al. Asymptomatic Atrial Fibrillation: Demographic Features and Prognostic Information From the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study Am Heart J. 2005; 149(4):657-663.
37. Verma A, Natale A. Should atrial fibrillation ablation be considered first-line therapy for some patients? Why atrial fibrillation ablation should be considered first-line therapy for some patients. Circulation 2005;112:1214-1222.
38. Cappato R, Calkins H, Chen SA, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005; 111:1100-1105.
39. Nilsson B.; Chen X.; Pehrson S.; Hilden J.; Svendsen J.H. Increased resting heart rate following radiofrequency catheter ablation for atrial fibrillation. Europace. 2005; 7(5):415-20.
40. Pappone C., Santinelli V. et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 2004: 109(3)327-34.
Рецензия
Для цитирования:
Лебедев Д.С., Маринин В.А., Оршанская В.С. ОСТИАЛЬНАЯ АБЛАЦИЯ ЛЕГОЧНЫХ ВЕН У ПАЦИЕНТОВ C РАЗНЫМИ ФОРМАМИ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ. Вестник аритмологии. 2006;(45):35-41.
For citation:
Lebedev D.S., Marinin V.A., Orshanskaya V.S. OSTIAL ABLATION OF PULMONARY VEINS IN PATIENTS WITH DIFFERENT TYPES OF ATRIAL FIBRILLATION. Journal of Arrhythmology. 2006;(45):35-41. (In Russ.)
Просмотров:
158
Послать статью по эл. почте 